Unichem Laboratories Limited (BOM:506690)
India · Delayed Price · Currency is INR | Market Cap | 22.77B -53.6% |
| Revenue (ttm) | 22.14B +16.3% |
| Net Income | 2.95B |
| EPS | 41.79 |
| Shares Out | 70.41M |
| PE Ratio | 7.74 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,669 |
| Average Volume | 2,912 |
| Open | 315.60 |
| Previous Close | 330.50 |
| Day's Range | 311.00 - 324.65 |
| 52-Week Range | 311.00 - 727.95 |
| Beta | -0.42 |
| RSI | 23.93 |
| Earnings Date | Feb 5, 2026 |
About Unichem Laboratories
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves... [Read more]
Financial Performance
Financial StatementsNews
Unichem Laboratories shares fall 3% after €19.49 million EU penalty demand in perindopril case
Shares of Unichem Laboratories Ltd slipped 3.21% to ₹492.05 on Thursday, September 18, after the company disclosed that it has received a demand notice from the European Commission seeking payment of ...
Unichem Pharmaceuticals recalls mislabeled Cyclobenzaprine tablets in US over safety concerns
Unichem Pharmaceuticals (USA) Inc., a wholly owned subsidiary of Unichem Laboratories, has announced a voluntary nationwide recall of one lot of Cyclobenzaprine Hydrochloride Tablets USP, 10 mg in the...
Unichem Laboratories’ Roha API facility gets VAI classification from USFDA
Unichem Laboratories has shared an important update regarding its Roha Active Pharmaceutical Ingredients (API) facility. Following the recent inspection conducted by the United States Food and Drug Ad...
Unichem Laboratories shares drop 4% after USFDA flags 3 procedural issues at Roha facility
Shares of Unichem Laboratories fell 4.19% to Rs 562.05 during trading today after the company disclosed that the US Food and Drug Administration (USFDA) made three observations during its recent inspe...
Unichem Labs Q4 Results: Revenue up 27.9% YoY to Rs 587.18 crore, company swings back to net profit
Unichem Laboratories Ltd reported a significant improvement in profitability for the quarter ended March 31, 2025 (Q4 FY25). The company posted a consolidated net profit of ₹52.97 crore, compared to a...
Unichem Laboratories receives USFDA EIR for Pithampur facility; inspection classified as VAI
Unichem Laboratories Limited on Wednesday announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Pithampur API fac...
Unichem Laboratories shares rise 2.35% as API plant expansion boosts production capacity
Shares of Unichem Laboratories Limited surged as the company announced the successful completion of Phase I of its Active Pharmaceutical Ingredient (API) plant expansion at Pithampur. This strategic m...
Unichem Laboratories completes Phase I expansion of API plant at Pithampur with Rs 200 crore investment
Unichem Laboratories Limited has announced the successful completion of Phase I of its Active Pharmaceutical Ingredient (API) plant expansion at Pithampur. The company informed the stock exchanges tha...
Unichem Laboratories Q3 results: Revenue rises 14.4% YoY to Rs 533 crore, Net profit falls 21% YoY
Unichem Laboratories Limited reported a solid financial performance for the third quarter ended December 31, 2024 (Q3 FY25), with revenue from operations increasing by 14.4% year-on-year (YoY) to Rs 5...